Category Archives: Biosimilar

Biopharma, Biosimilar, Infusion, Specialty Pharmacy

Celltrion Healthcare Contracts with CarePartners Pharmacy for Yuflyma

Posted on by John Santilli
17
Oct

Celltrion Healthcare recently signed an agreement with Libertyville, IL-based CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the U.S. market

Continue reading →
Affordable Care Act, Biosimilar, Health Insurance

ACA Supreme Court Deliberations and Any Impact on Biosimilars?

Posted on by Dr. Randy
28
Nov

If the court strikes down the ACA entirely, biosimilars on the U.S. market or in the FDA approval pipeline would have to either be grandfathered in or face a regulatory wind-down

Continue reading →